Success Metrics

Clinical Success Rate
100.0%

Based on 16 completed trials

Completion Rate
100%(16/16)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
16
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution16 total trials
N/ANon-phased studies
16(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

16 of 16 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Completed(16)

Detailed Status

Completed16

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A16 (100.0%)

Trials by Status

completed16100%

Recent Activity

Clinical Trials (16)

Drug Details

Intervention Type
DRUG
Total Trials
16